Previous Page  1187 / 1816 Next Page
Information
Show Menu
Previous Page 1187 / 1816 Next Page
Page Background

Introduction

Widespread use of systemic treatments in breast cancer

-Hormone therapy

-Chemotherapy

-Targeted therapy (Trastuzumab, Avastin, Pertuzumab, TDM1,

immunotherapy)

All these treatments have an impact on local control and survival

In the adjuvant setting, they are usually delivered sequentially

Few studies have evaluated the delivery of concurrent radiotherapy and

systemic treatments